Trial
NCT05468203
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The George Institute
Collaborators
University Medical Center Groningen; Australian and New Zealand Intensive Care Society Clinical Trials Group
Condition
Acute Kidney Injury
Intervention
Dapagliflozin 10mg Tab
Why stopped
The vanguard phase is complete. Further phases did not proceed due to funding constraints. A revised methodology is planned, requiring a new protocol and approvals.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-30